![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Meso Scale Diagnostics Wins FDA Nod for IVD Assay
Meso Scale Diagnostics Wins FDA Nod for IVD Assay
January 31, 2018
Maryland-based immunoassay developer Meso Scale Diagnostics received FDA clearance for its conventional C-reactive protein assay for in vitro diagnostic use.
The CRP assay features the company’s proprietary MULTI-ARRAY technology and its MESO SECTOR S 700 for the detection of analytes in bodily fluids.
The assay provides an “attractive alternative” to traditional diagnostic test systems, the company said.
Upcoming Events
-
21Oct